发明申请
US20100203043A1 TREATMENT AND DIAGNOSIS OF METASTATIC PROSTATE CANCER WITH INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)
审中-公开
治疗和诊断与EPIDERM生长因子受体（EGFR）的抑制剂分离前列腺癌
- 专利标题： TREATMENT AND DIAGNOSIS OF METASTATIC PROSTATE CANCER WITH INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)
- 专利标题（中）： 治疗和诊断与EPIDERM生长因子受体（EGFR）的抑制剂分离前列腺癌
-
申请号： US12450743申请日： 2008-04-11
-
公开(公告)号： US20100203043A1公开(公告)日： 2010-08-12
- 发明人: Anne H. Ree , Ase Bratland , Pieter Jacob Boender , Robby Ruijtenbeek
- 申请人： Anne H. Ree , Ase Bratland , Pieter Jacob Boender , Robby Ruijtenbeek
- 优先权： DKPA200700547 20070413
- 国际申请： PCT/EP2008/054432 WO 20080411
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61K31/5377 ; A61K31/517 ; A61K31/4706 ; A61K38/09 ; A61P35/00 ; A61P35/04 ; G01N33/53
摘要：
The present invention relates to a method for the treatment, prevention and/or diagnosis of metastatic prostate cancer. More specifically inhibitors of Epidermal Growth Factor Receptor (EGFR) are used in the preparation of a pharmaceutical composition for treating or preventing metastatic prostate cancer. The EGFR inhibitors can for instance be EGFR inhibitors, EGFR signaling inhibitors and/or inhibitors of kinases downstream of EGFR kinases. The EGFR inhibitors can also be used in detection, screening, prediction and treatment monitoring methods for metastatic prostate cancer.
信息查询
